Overview of Dr. Ortiz
Dr. Michael Ortiz is a pediatric hematologist/oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and New York-Presbyterian Hospital. He received his medical degree from University of Florida College of Medicine and has been in practice 7 years. He is one of 135 doctors at New York-Presbyterian Hospital and one of 95 doctors at Memorial Sloan Kettering Cancer Center who specialize in Pediatric Hematology & Oncology. He has more than 40 publications and over 500 citings.
Office
1275 York Avenue
New York, NY 10065
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2014 - 2017
Children's National HospitalChief Residency, Pediatrics, 2013 - 2014- Children's National HospitalResidency, Pediatrics, 2010 - 2013
University of Florida College of MedicineClass of 2010, M.D.
Certifications & Licensure
FL State Medical License 2023 - Present
NJ State Medical License 2024 - 2025
NY State Medical License 2014 - 2025
DC State Medical License 2010 - 2014- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors Start of enrollment: 2020 Dec 10
Roles: Contact, Principal Investigator
- A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment Start of enrollment: 2021 Jun 09
Roles: Principal Investigator, Contact
- A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors Start of enrollment: 2023 Aug 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Pediatric Leukemia Roadmaps Are a Guide for Positive Metastatic Bone Sarcoma Trials.Damon R Reed, Asmin Tulpule, Jonathan Metts, Matteo Trucco, Mark Robertson-Tessi
Journal of Clinical Oncology. 2024-09-01 - Intraoperative radiation therapy for pediatric sarcomas and other solid tumors.Brianna Conte, Dana L Casey, Kathryn R Tringale, Michael P LaQuaglia, J Ted Gerstle
Pediatric Blood & Cancer. 2024-06-01 - 3 citationsElimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models.Fabian F Pusch, Heathcliff Dorado García, Robin Xu, Dennis Gürgen, Yi Bei
Molecular Cancer Therapeutics. 2024-04-02
Grant Support
- NCIMemorial Sloan Kettering Cancer Center2017–2020
External Links
- MSK Kidshttps://www.mskcc.org/cancer-care/doctors/michael-ortiz
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
